Variability in drug metabolism: importance of genetic constitution
- 1 April 1987
- journal article
- review article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 9 (2) , 85-90
- https://doi.org/10.1007/bf01960741
Abstract
In man wide variability exists in the rate of metabolism of drugs and among factors which contribute to this phenomenon genetic constitution is of major importance. The metabolism of a number of drugs is subject to polymorphism and the frequency distribution of particular pharmacokinetic parameters shows bimodality, with poor (PM) and extensive metabolizers (EM). Acetylation of a number of drugs is known to be polymorphic and the incidence of poor metabolizers varies markedly among different populations. Debrisoquine and sparteine are frequently applied model substrates for the characterization of a polymorphism in oxidative metabolism. Polymorphic drug oxidation may have important clinical implications, because when standard dosage regimens are applied plasma concentrations will reach far above the maximum acceptable in poor metabolizers and consequently side effects may arise. Regarding the multiplicity of the drug oxidizing enzyme system (cytochrome P-450) it could be of interest to combine model substrates in a cocktail to be able to characterize human subjects simultaneously for a number of independent polymorphisms.Keywords
This publication has 29 references indexed in Scilit:
- Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenololXenobiotica, 1986
- The molecular mechanisms of two common polymorphisms of drug oxidation-evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidationXenobiotica, 1986
- The genetic polymorphism of sparteine metabolismXenobiotica, 1986
- Characterization of a common genetic defect of cytochrome P-450 function (debrisoquine-sparteine type polymorphism) — Increased michaelis constant (km) and loss of stereoselectivity of bufuralol 1′-hydroxylation in poor metabolizersBiochemical and Biophysical Research Communications, 1984
- Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylationFEBS Letters, 1984
- Impairment of Phenytoin Parahydroxylation as a Cause of Severe IntoxicationTherapeutic Drug Monitoring, 1983
- Ethnic Differences in Drug MetabolismClinical Pharmacokinetics, 1982
- Defective Oxidation of DrugsClinical Pharmacokinetics, 1982
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981
- Disease and Acetylation PolymorphismClinical Pharmacokinetics, 1977